Coloplast A/S
General ticker "CLPBF" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $17.1B (TTM average)
Coloplast A/S does not follow the US Stock Market performance with the rate: -28.5%.
Estimated limits based on current volatility of 0.1%: low 68.30$, high 68.37$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2026-05-19, amount 0.78$ (Y2.28%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [78.83$, 116.83$]
- 2026-09-30 to 2027-09-30 estimated range: [82.87$, 121.53$]
Financial Metrics affecting the CLPBF estimates:
- Negative: with PPE of 33.9 at the end of fiscal year the price was high
- Positive: 22.58 < Operating profit margin, % of 27.19
- Positive: 4.90 < Operating cash flow per share per price, % of 5.16
- Negative: 0.33 < Interest expense per share per price, % of 0.64
- Positive: 5.14 < Return on assets ratio (scaled to [-100,100]) of 6.99
- Positive: 25.20 < Shareholder equity ratio, % of 33.33 <= 34.41
- Negative: negative Industry operating income (median)
- Negative: Investing cash flow per share per price, % of -0.97 <= -0.14
Short-term CLPBF quotes
Long-term CLPBF plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | DKK24,500.00MM | DKK27,030.00MM | DKK27,821.00MM |
| Operating Expenses | DKK17,729.00MM | DKK19,710.00MM | DKK20,256.00MM |
| Operating Income | DKK6,771.00MM | DKK7,320.00MM | DKK7,565.00MM |
| Non-Operating Income | DKK-746.00MM | DKK-925.00MM | DKK-1,420.00MM |
| Interest Expense | DKK638.00MM | DKK795.00MM | DKK823.43MM |
| R&D Expense | DKK872.00MM | DKK913.00MM | DKK898.29MM |
| Income(Loss) | DKK6,025.00MM | DKK6,395.00MM | DKK6,145.00MM |
| Taxes | DKK1,242.00MM | DKK1,343.00MM | DKK2,516.00MM |
| Net Income(Loss)* | DKK2,795.00MM | DKK2,784.00MM | DKK3,629.00MM |
| Stockholders Equity | DKK17,299.00MM | DKK17,942.00MM | DKK16,091.00MM |
| Inventory | DKK3,522.00MM | DKK3,672.00MM | DKK3,912.00MM |
| Assets | DKK48,159.00MM | DKK48,073.00MM | DKK48,275.00MM |
| Operating Cash Flow | DKK4,226.00MM | DKK2,766.00MM | DKK6,632.00MM |
| Capital expenditure | DKK1,241.00MM | DKK1,346.00MM | DKK1,304.00MM |
| Investing Cash Flow | DKK-8,957.00MM | DKK-1,336.00MM | DKK-1,249.00MM |
| Financing Cash Flow | DKK5,265.00MM | DKK-1,518.00MM | DKK-5,177.00MM |
| Earnings Per Share** | DKK12.97 | DKK12.38 | DKK16.10 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.